Ecraprost Uses, Dosage, Side Effects and more
Ecraprost is under investigation in clinical trial NCT00059657 (Efficacy/safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease).
| Attribute | Details |
|---|---|
| Trade Name | Ecraprost |
| Generic | Ecraprost |
| Ecraprost Other Names | Circulase, Ecraprost |
| Type | |
| Formula | C28H48O6 |
| Weight | Average: 480.686 Monoisotopic: 480.345089266 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
